Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank29
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P29
Within normal range
vs 5Y Ago
-4.1x
Contraction
Streak
3 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$-160.28M+34.0%
2024$-242.77M+10.5%
2023$-271.13M+3.9%
2022$-282.24M-12.6%
2021$-250.76M-743.4%
2020$38.97M+154.5%
2019$-71.58M+23.0%
2018$-92.92M-15.0%
2017$-80.83M-20.2%
2016$-67.27M-